Reduced microbiome alpha diversity in young patients with ADHD

PLoS ONE

Volumn 13, Issue 7, 2018, Pages

  Prehn Kristensen, Alexander ^a   Zimmermann, Alexandra ^a   Tittmann, Lukas ^a   Lieb, Wolfgang ^a   Schreiber, Stefan ^a   Baving, Lioba ^a   Fischer, Annegret ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA 16S; METHYLPHENIDATE; BACTERIAL DNA; BACTERIAL RNA; RIBOSOME DNA; RNA 16S;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BACTEROIDACEAE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; HUMAN; INTESTINE FLORA; JUVENILE ATTENTION DEFICIT DISORDER; MALE; MICROBIAL DIVERSITY; MIRCOBIAL ALPHA DIVERSITY; MIRCOBIAL BETA DIVERSITY; NEISSERIA; NEXT GENERATION SEQUENCING; PARABACTEROIDES; PATHOPHYSIOLOGY; PREVOTELLACEAE; QUESTIONNAIRE; RATING SCALE; SCHOOL CHILD; SPECIES IDENTIFICATION; SPECIES RICHNESS; BIODIVERSITY; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIODIVERSITY; CHILD; DNA, BACTERIAL; DNA, RIBOSOMAL; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; NEISSERIA; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S;

EID: 85050586977     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0200728     Document Type: Article

References (103)

1. Polanczyk GV, Salum GA, Sugaya LS, Caye A, Rohde LA. Annual research review: A meta-analysis of the worldwide prevalence of mental disorders in children and adolescents. J Child Psychol Psychiatry. 2015; 56(3):345–65. Epub 2015/02/05. https://doi.org/10.1111/jcpp.12381 PMID: 25649325.
2. Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol. 2014; 43 (2):434–42. Epub 2014/01/28. https://doi.org/10.1093/ije/dyt261 PMID: 24464188; PubMed Central PMCID: PMCPmc4817588.
3. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association 2013.
4. Bellgrove MA, Mattingley JB. Molecular genetics of attention. ANYAS. 2008; 1129:200–12. https://doi.org/10.1196/annals.1417.013 PMID: 18591481.
5. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular Genetics of Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry. 2005; 57:1313–23. https://doi.org/10.1016/j.biopsych.2004.11.024 PMID: 15950004
6. Wu J, Xiao H, Sun H, Zou L, Zhu LQ. Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol Neurobiol. 2012; 45(3):605–20. Epub 2012/05/23. https://doi.org/10.1007/s12035-012-8278-5PMID: 22610946.
7. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288(14):1740–8. PMID: 12365958.
8. Frodl T, Skokauskas N. Meta-analysis of structural MRI studies in children and adults with attention deficit hyperactivity disorder indicates treatment effects. Acta Psychiatr Scand. 2012; 125(2):114–26. Epub 2011/11/29. https://doi.org/10.1111/j.1600-0447.2011.01786.x PMID: 22118249.
9. Nakao T, Radua J, Rubia K, Mataix-Cols D. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. AJ Psychiatry. 2011; 168 (11):1154–63. Epub 2011/08/26. https://doi.org/10.1176/appi.ajp.2011.11020281 PMID: 21865529.
10. Shaw P, Eckstrand K, Sharp W, Blumenthal J, Lerch JP, Greenstein D, et al. Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A. 2007; 104 (49):19649–54. Epub 2007/11/21. doi: 0707741104 [pii] https://doi.org/10.1073/pnas.0707741104PMID: 18024590; PubMed Central PMCID: PMC2148343.
11. Shaw P, Rabin C. New insights into attention-deficit/hyperactivity disorder using structural neuroimag-ing. Curr Psychiatry Rep. 2009; 11(5):393–8. Epub 2009/09/30. PMID: 19785981.
12. Hawi Z, Cummins TD, Tong J, Johnson B, Lau R, Samarrai W, et al. The molecular genetic architecture of attention deficit hyperactivity disorder. Mol Psychiatry. 2015; 20(3):289–97. Epub 2015/01/21. https://doi.org/10.1038/mp.2014.183 PMID: 25600112.
13. Middeldorp CM, Hammerschlag AR, Ouwens KG, Groen-Blokhuis MM, Pourcain BS, Greven CU, et al. A Genome-Wide Association Meta-Analysis of Attention-Deficit/Hyperactivity Disorder Symptoms in Population-Based Pediatric Cohorts. J Am Acad Child Adolesc Psychiatry. 2016; 55(10):896–905.e6. Epub 2016/09/25. https://doi.org/10.1016/j.jaac.2016.05.025 PMID: 27663945; PubMed Central PMCID: PMCPmc5068552.
14. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005; 366(9481):237–48. Epub 2005/07/19. https://doi.org/10.1016/S0140-6736(05)66915-2 PMID: 16023516.
15. Lindstrom K, Lindblad F, Hjern A. Preterm birth and attention-deficit/hyperactivity disorder in schoolchildren. Pediatrics. 2011; 127(5):858–65. Epub 2011/04/20. https://doi.org/10.1542/peds.2010-1279PMID: 21502231.
16. Capusan AJ, Kuja-Halkola R, Bendtsen P, Viding E, McCrory E, Marteinsdottir I, et al. Childhood maltreatment and attention deficit hyperactivity disorder symptoms in adults: a large twin study. Psychol Med. 2016; 46(12):2637–46. Epub 2016/07/05. https://doi.org/10.1017/S0033291716001021 PMID: 27376862.
17. Margari F, Craig F, Petruzzelli MG, Lamanna A, Matera E, Margari L. Parents psychopathology of children with Attention Deficit Hyperactivity Disorder. Res Dev Disabil. 2013; 34(3):1036–43. Epub 2013/ 01/08. https://doi.org/10.1016/j.ridd.2012.12.001 PMID: 23291521.
18. Bener A, Kamal M, Bener H, Bhugra D. Higher prevalence of iron deficiency as strong predictor of attention deficit hyperactivity disorder in children. Annals of medical and health sciences research. 2014; 4(Suppl 3):S291–7. Epub 2014/11/05. https://doi.org/10.4103/2141-9248.141974 PMID: 25364604; PubMed Central PMCID: PMCPmc4212392.
19. Dolina S, Margalit D, Malitsky S, Rabinkov A. Attention-deficit hyperactivity disorder (ADHD) as a pyri-doxine-dependent condition: urinary diagnostic biomarkers. Med Hypotheses. 2014; 82(1):111–6. Epub 2013/12/11. https://doi.org/10.1016/j.mehy.2013.11.018 PMID: 24321736.
20. Niederhofer H, Pittschieler K. A preliminary investigation of ADHD symptoms in persons with celiac disease. J Atten Disord. 2006; 10(2):200–4. Epub 2006/11/07. https://doi.org/10.1177/1087054706292109 PMID: 17085630.
21. Percinel I, Yazici KU, Ustundag B. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Child Psychiatry Hum Dev. 2016; 47(2):259–69. Epub 2015/06/21. https://doi.org/10.1007/s10578-015-0562-y PMID: 26092605.
22. Salehi B, Mohammadbeigi A, Sheykholeslam H, Moshiri E, Dorreh F. Omega-3 and Zinc supplementation as complementary therapies in children with attention-deficit/hyperactivity disorder. Journal of research in pharmacy practice. 2016; 5(1):22–6. Epub 2016/03/18. https://doi.org/10.4103/2279042X.176561 PMID: 26985432; PubMed Central PMCID: PMCPmc4776543.
23. Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther. 2015; 37(5):984–95. Epub 2015/06/06. https://doi.org/10.1016/j.clinthera.2015.04.002 PMID: 26046241; PubMed Central PMCID: PMCPmc4458706.
24. Verlaet AA, Noriega DB, Hermans N, Savelkoul HF. Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur Child Adolesc Psychiatry. 2014; 23(7):519–29. Epub 2014/02/05. https://doi.org/10.1007/s00787-014-0522-2 PMID: 24493267.
25. Esparham A, Evans RG, Wagner LE, Drisko JA. Pediatric Integrative Medicine Approaches to Attention Deficit Hyperactivity Disorder (ADHD). Children (Basel, Switzerland). 2014; 1(2):186–207. Epub 2014/01/01. https://doi.org/10.3390/children1020186 PMID: 27417475; PubMed Central PMCID: PMCPmc4928725.
26. Flint HJ, Duncan SH, Scott KP, Louis P. Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc. 2015; 74(1):13–22. Epub 2014/10/01. https://doi.org/10.1017/S0029665114001463 PMID: 25268552.
27. Krishnan C, Santos L, Peterson MD, Ehinger M. Safety of noninvasive brain stimulation in children and adolescents. Brain stimulation. 2015; 8(1):76–87. Epub 2014/12/17. https://doi.org/10.1016/j.brs.2014.10.012 PMID: 25499471; PubMed Central PMCID: PMCPmc4459719.
28. Ussar S, Griffin NW, Bezy O, Fujisaka S, Vienberg S, Softic S, et al. Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. Cell metabolism. 2015; 22(3):516–30. Epub 2015/08/25. https://doi.org/10.1016/j.cmet.2015.07.007PMID: 26299453; PubMed Central PMCID: PMCPmc4570502.
29. Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016; 65(2):330–9. Epub 2015/09/05. https://doi.org/10.1136/gutjnl-2015-309990 PMID: 26338727; PubMed Central PMCID: PMCPmc4752653.
30. Herpertz-Dahlmann B, Seitz J, Baines J. Food matters: how the microbiome and gut-brain interaction might impact the development and course of anorexia nervosa. Eur Child Adolesc Psychiatry. 2017. Epub 2017/02/02. https://doi.org/10.1007/s00787-017-0945-7 PMID: 28144744.
31. Rieder R, Wisniewski PJ, Alderman BL, Campbell SC. Microbes and mental health: A review. Brain Behav Immun. 2017. Epub 2017/01/31. https://doi.org/10.1016/j.bbi.2017.01.016 PMID: 28131791.
32. Santocchi E, Guiducci L, Fulceri F, Billeci L, Buzzigoli E, Apicella F, et al. Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters. BMC psychiatry. 2016; 16:183. Epub 2016/06/05. https://doi.org/10.1186/s12888-016-0887-5 PMID: 27260271; PubMed Central PMCID: PMCPmc4893248.
33. Sfera A, Osorio C, Inderias LA, Parker V, Price AI, Cummings M. The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients. Frontiers in psychiatry. 2017; 8:20. Epub 2017/03/01. https://doi.org/10.3389/fpsyt.2017.00020 PMID: 28243210; PubMed Central PMCID: PMCPmc5303716.
34. Wallace CJ, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Annals of general psychiatry. 2017; 16:14. Epub 2017/02/28. https://doi.org/10.1186/s12991-017-0138-2 PMID: 28239408; PubMed Central PMCID: PMCPmc5319175.
35. Tuohy KM, editor Mode Of Delivery, Route Of Delivery And Diet All Regulate Infant Microbiota And Metabolome. J Pediatr Gastroenterol Nutr; 2016: LWW.
36. Fujimura KE, Sitarik AR, Havstad S, Lin DL, Levan S, Fadrosh D, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. 2016; 22(10):1187–91. https://doi.org/10.1038/nm.4176 PMID: 27618652.
37. Cenit MC, Nuevo IC, Codoner-Franch P, Dinan TG, Sanz Y. Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition. Eur Child Adolesc Psychiatry. 2017. Epub 2017/03/16. https://doi.org/10.1007/s00787-017-0969-z PMID: 28289903.
38. Putignani L, Del Chierico F, Petrucca A, Vernocchi P, Dallapiccola B. The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood. Pediatr Res. 2014; 76(1):2–10. Epub 2014/04/16. https://doi.org/10.1038/pr.2014.49 PMID: 24732106.
39. Desbonnet L, Clarke G, Shanahan F, Dinan TG, Cryan JF. Microbiota is essential for social development in the mouse. Mol Psychiatry. 2014; 19(2):146–8. Epub 2013/05/22. https://doi.org/10.1038/mp.2013.65 PMID: 23689536; PubMed Central PMCID: PMCPmc3903109.
40. Li W, Dowd SE, Scurlock B, Acosta-Martinez V, Lyte M. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav. 2009; 96(4–5):557–67. Epub 2009/01/13. https://doi.org/10.1016/j.physbeh.2008.12.004 PMID: 19135464.
41. Savignac HM, Tramullas M, Kiely B, Dinan TG, Cryan JF. Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res. 2015; 287:59–72. Epub 2015/03/22. https://doi.org/10.1016/j.bbr.2015.02.044 PMID: 25794930.
42. De Angelis M, Francavilla R, Piccolo M, De Giacomo A, Gobbetti M. Autism spectrum disorders and intestinal microbiota. Gut microbes. 2015; 6(3):207–13. Epub 2015/04/04. https://doi.org/10.1080/19490976.2015.1035855 PMID: 25835343; PubMed Central PMCID: PMCPmc4616908.
43. Zheng P, Zeng B, Zhou C, Liu M, Fang Z, Xu X, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol Psychiatry. 2016; 21 (6):786–96. Epub 2016/04/14. https://doi.org/10.1038/mp.2016.44 PMID: 27067014.
44. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. The Journal of physiology. 2004; 558(Pt 1):263–75. Epub 2004/05/11. https://doi.org/10.1113/jphysiol.2004.063388 PMID: 15133062; PubMed Central PMCID: PMCPmc1664925.
45. Partty A, Kalliomaki M, Wacklin P, Salminen S, Isolauri E. A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. Pediatr Res. 2015; 77(6):823–8. Epub 2015/03/12. https://doi.org/10.1038/pr.2015.51 PMID: 25760553.
46. Consortium HMP. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207–14. Epub 2012/06/16. https://doi.org/10.1038/nature11234 PMID: 22699609; PubMed Central PMCID: PMCPmc3564958.
47. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012; 489(7415):220–30. Epub 2012/09/14. https://doi.org/10.1038/nature11550 PMID: 22972295; PubMed Central PMCID: PMCPmc3577372.
48. Delmo C, Weiffenbach O, Gabriel M, Bölte S, Marchio E, Poustka F. Kiddie-SADS-present and lifetime version (K-SADS-PL), 3rd edn. 3rd ed. Frankfurt, Germany: Clinic of Child and Adolescent Psychiatry; 2000.
49. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, et al. Schedule for affective disorders and schizophrenia for school-age children—Present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997; 36:980–8. https://doi.org/10.1097/00004583-199707000-00021 PMID: 9204677
50. Achenbach TM. Manual for the child behavior checklist/4-18 and 1991 Profile. Burlington,Vermont: Department of Psychiatry, University of Vermont; 1991.
51. Döpfner M, Görtz-Dorten A, Lehmkuhl G. Diagnostik-System für psychische Störungen nach ICD-10 und DSM-IV für Kinder und Jugendliche-II: DISYPS-II; Manual: Huber; 2008.
52. Retz-Junginger P, Retz W, Schneider M, Schwitzgebel P, Steinbach E, Hengesch G, et al. [Gender differences in self-descriptions of child psychopathology in attention deficit hyperactivity disorder]. Nervenarzt. 2007; 78(9):1046–51. Epub 2007/02/03. https://doi.org/10.1007/s00115-006-2242-4 PMID: 17268790.
53. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. AJ Psychiatry. 1993; 150(6):885–90. Epub 1993/06/01. https://doi.org/10.1176/ajp.150.6.885 PMID: 8494063.
54. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, et al. [Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults]. Nervenarzt. 2002; 73(9):830–8. Epub 2002/09/07. https://doi.org/10.1007/s00115-001-1215-x PMID: 12215873.
55. Retz-Junginger P, Retz W, Blocher D, Stieglitz RD, Georg T, Supprian T, et al. [Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder]. Nervenarzt. 2003; 74(11):987–93. Epub 2003/11/05. https://doi.org/10.1007/s00115-002-1447-4 PMID: 14598035.
56. Rosler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T, et al. [Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist]. Nervenarzt. 2004; 75(9):888–95. Epub 2004/09/21. https://doi.org/10.1007/s00115-003-1622-2 PMID: 15378249.
57. Rösler M, Retz-Junginger P, Retz W, Stieglitz R. HASE–Homburger ADHS-Skalen für Erwachsene. Göttingen: Hogrefe. 2008.
58. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. The ISME journal. 2012; 6 (8):1621–4. Epub 2012/03/10. https://doi.org/10.1038/ismej.2012.8 PMID: 22402401; PubMed Central PMCID: PMCPmc3400413.
59. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009; 75(23):7537–41. Epub 2009/10/06. https://doi.org/10.1128/AEM.01541-09 PMID: 19801464; PubMed Central PMCID: PMCPmc2786419.
60. Legendre P, Gallagher ED. Ecologically meaningful transformations for ordination of species data. Oecologia. 2001; 129(2):271–80. Epub 2001/10/01. https://doi.org/10.1007/s004420100716 PMID: 28547606.
61. Borcard D, Gillet F, Legendre P. Numerical ecology with R: Springer Science & Business Media; 2011.
62. Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O’hara R, et al. Package ‘vegan’. Community ecology package, version. 2013; 2(9).
63. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome biology. 2011; 12(6):R60. Epub 2011/06/28. https://doi.org/10.1186/gb-2011-12-6-r60 PMID: 21702898; PubMed Central PMCID: PMCPmc3218848.
64. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011; 108(38):16050–5. Epub 2011/08/31. https://doi.org/10.1073/pnas.1102999108 PMID: 21876150; PubMed Central PMCID: PMCPmc3179073.
65. Dinan TG, Stilling RM, Stanton C, Cryan JF. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res. 2015; 63:1–9. Epub 2015/03/17. https://doi.org/10.1016/j.jpsychires.2015.02.021 PMID: 25772005.
66. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013; 36(5):305–12. Epub 2013/02/07. https://doi.org/10.1016/j.tins.2013.01.005PMID: 23384445.
67. Rea K, Dinan TG, Cryan JF. The microbiome: A key regulator of stress and neuroinflammation. Neurobiology of stress. 2016; 4:23–33. Epub 2016/12/17. https://doi.org/10.1016/j.ynstr.2016.03.001 PMID: 27981187; PubMed Central PMCID: PMCPmc5146205.
68. Liu G, Tang CM, Exley RM. Non-pathogenic Neisseria: members of an abundant, multi-habitat, diverse genus. Microbiology. 2015; 161(7):1297–312. Epub 2015/03/31. https://doi.org/10.1099/mic.0.000086 PMID: 25814039.
69. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001; 292 (5519):1115–8. Epub 2001/05/16. PMID: 11352068.
70. Berg S, Trollfors B, Hugosson S, Fernell E, Svensson E. Long-term follow-up of children with bacterial meningitis with emphasis on behavioural characteristics. Eur J Pediatr. 2002; 161(6):330–6. Epub 2002/05/25. https://doi.org/10.1007/s00431-002-0957-1 PMID: 12029452.
71. Wu H, Jerse AE. Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection. Infect Immun. 2006; 74(7):4094–103. Epub 2006/06/23. https://doi.org/10.1128/IAI.00433-06 PMID: 16790783; PubMed Central PMCID: PMCPmc1489707.
72. Brevik EJ, van Donkelaar MM, Weber H, Sanchez-Mora C, Jacob C, Rivero O, et al. Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder. Am J Med Genet B Neuropsy-chiatr Genet. 2016; 171(5):733–47. Epub 2016/03/30. https://doi.org/10.1002/ajmg.b.32434 PMID: 27021288; PubMed Central PMCID: PMCPmc5071721.
73. Sampson TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell host & microbe. 2015; 17(5):565–76. Epub 2015/05/15. https://doi.org/10.1016/j.chom.2015.04.011 PMID: 25974299; PubMed Central PMCID: PMCPmc4442490.
74. Zhu B, Wang X, Li L. Human gut microbiome: the second genome of human body. Protein & cell. 2010; 1(8):718–25. Epub 2011/01/05. https://doi.org/10.1007/s13238-010-0093-z PMID: 21203913; PubMed Central PMCID: PMCPmc4875195.
75. Lukiw WJ. The microbiome, microbial-generated proinflammatory neurotoxins, and Alzheimer’s disease. Journal of sport and health science. 2016; 5(4):393–6. Epub 2017/04/28. https://doi.org/10.1016/j.jshs.2016.08.008 PMID: 28446989; PubMed Central PMCID: PMCPmc5403149.
76. Yunes RA, Poluektova EU, Dyachkova MS, Klimina KM, Kovtun AS, Averina OV, et al. GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. Anaerobe. 2016; 42:197–204. Epub 2016/10/31. https://doi.org/10.1016/j.anaerobe.2016.10.011 PMID: 27794467.
77. Edden RA, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH. Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2012; 69(7):750–3. Epub 2012/07/04. https://doi.org/10.1001/archgenpsychiatry.2011.2280 PMID: 22752239; PubMed Central PMCID: PMCPmc3970207.
78. Clark A, Mach N. Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. Journal of the International Society of Sports Nutrition. 2016; 13:43. Epub 2016/12/ 08. https://doi.org/10.1186/s12970-016-0155-6 PMID: 27924137; PubMed Central PMCID: PMCPmc5121944.
79. Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis. Microbial endocrinology: the microbiota-gut-brain axis in health and disease: Springer; 2014. p. 195–219.
80. Thapar A, Cooper M. Attention deficit hyperactivity disorder. Lancet. 2016; 387(10024):1240–50. Epub 2015/09/21. https://doi.org/10.1016/S0140-6736(15)00238-X PMID: 26386541.
81. Agans R, Rigsbee L, Kenche H, Michail S, Khamis HJ, Paliy O. Distal gut microbiota of adolescent children is different from that of adults. FEMS microbiology ecology. 2011; 77(2):404–12. Epub 2011/05/ 05. https://doi.org/10.1111/j.1574-6941.2011.01120.x PMID: 21539582; PubMed Central PMCID: PMCPmc4502954.
82. Haro C, Rangel-Zuniga OA, Alcala-Diaz JF, Gomez-Delgado F, Perez-Martinez P, Delgado-Lista J, et al. Intestinal Microbiota Is Influenced by Gender and Body Mass Index. 2016; 11(5):e0154090. https://doi.org/10.1371/journal.pone.0154090 PMID: 27228093.
83. Conlon MA, Bird AR. The impact of diet and lifestyle on gut microbiota and human health. Nutrients. 2014; 7(1):17–44. Epub 2014/12/30. https://doi.org/10.3390/nu7010017 PMID: 25545101; PubMed Central PMCID: PMCPmc4303825.
84. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014; 505(7484):559–63. Epub 2013/12/18. https://doi.org/10.1038/nature12820 PMID: 24336217; PubMed Central PMCID: PMCPmc3957428.
85. Lisko DJ, Johnston GP, Johnston CG. Effects of Dietary Yogurt on the Healthy Human Gastrointestinal (GI) Microbiome. Microorganisms. 2017; 5(1). Epub 2017/02/18. https://doi.org/10.3390/microorganisms5010006 PMID: 28212267; PubMed Central PMCID: PMCPmc5374383.
86. Dore J, Blottiere H. The influence of diet on the gut microbiota and its consequences for health. Curr Opin Biotechnol. 2015; 32:195–9. Epub 2015/01/24. https://doi.org/10.1016/j.copbio.2015.01.002PMID: 25615931.
87. Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. AJ Psychiatry. 2013; 170(3):275–89. Epub 2013/01/31. https://doi.org/10.1176/appi.ajp.2012.12070991 PMID: 23360949.
88. Pelsser LM, Frankena K, Toorman J, Rodrigues Pereira R. Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD. PLoS One. 2017; 12(1):e0169277. Epub 2017/01/26. https://doi.org/10.1371/journal.pone.0169277 PMID: 28121994; PubMed Central PMCID: PMCPMC5266211 received honoraria for applying the RED protocol in the Netherlands. RRP and LMP received travel grants and honoraria for speaking or participations at meetings. RRP is a board member of ADHD in Practice, Impuls & Woortblind and Dutch ADHD Quality Standard. All other authors declare to have no competing interests. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
89. Ly V, Bottelier M, Hoekstra PJ, Arias Vasquez A, Buitelaar JK, Rommelse NN. Elimination diets’ efficacy and mechanisms in attention deficit hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry. 2017. Epub 2017/02/13. https://doi.org/10.1007/s00787-017-0959-1 PMID: 28190137.
90. Bonvicini C, Faraone SV, Scassellati C. Attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies. Mol Psychiatry. 2016; 21(11):1643. Epub 2016/10/21. https://doi.org/10.1038/mp.2016.128 PMID: 27502472; PubMed Central PMCID: PMCPmc5078851.
91. Ludolph AG, Kassubek J, Schmeck K, Glaser C, Wunderlich A, Buck AK, et al. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study. Neuroimage. 2008; 41(3):718–27. Epub 2008/04/22. doi: S1053-8119(08)00169-9 [pii] https://doi.org/10.1016/j.neuroimage.2008.02.025 PMID: 18424180.
92. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. AJ Psychiatry. 1998; 155(10):1325–31. Epub 1998/10/10. https://doi.org/10.1176/ajp.155.10.1325 PMID: 9766762.
93. Coghill DR, Seth S, Pedroso S, Usala T, Currie J, Gagliano A. Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis. Biol Psychiatry. 2014; 76(8):603–15. Epub 2013/11/16. https://doi.org/10.1016/j.biopsych.2013.10.005 PMID: 24231201.
94. De Crescenzo F, Armando M, Mazzone L, Ciliberto M, Sciannamea M, Figueroa C, et al. The use of actigraphy in the monitoring of methylphenidate versus placebo in ADHD: a meta-analysis. Atten Defic Hyperact Disord. 2014; 6(1):49–58. Epub 2013/11/30. https://doi.org/10.1007/s12402-013-0122-xPMID: 24287735.
95. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, et al. European clinical guidelines for hyperkinetic disorder—first upgrade. Eur Child Adolesc Psychiatry. 2004; 13 Suppl 1:I7–30. Epub 2004/08/24. https://doi.org/10.1007/s00787-004-1002-x PMID: 15322953.
96. Vastag B. Pay attention: ritalin acts much like cocaine. Jama. 2001; 286(8):905–6. Epub 2001/08/31. PMID: 11509035.
97. Fowler JS, Volkow ND, Wang GJ, Gatley SJ, Logan J. [(11)]Cocaine: PET studies of cocaine pharma-cokinetics, dopamine transporter availability and dopamine transporter occupancy. Nucl Med Biol. 2001; 28(5):561–72. Epub 2001/08/23. PMID: 11516700.
98. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 1987; 237(4819):1219–23. Epub 1987/09/04. PMID: 2820058.
99. Zhu J, Reith ME. Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS & neurological disorders drug targets. 2008; 7(5):393–409. Epub 2009/01/ 09. PMID: 19128199; PubMed Central PMCID: PMCPmc3133725.
100. Kiraly DD, Walker DM, Calipari ES, Labonte B, Issler O, Pena CJ, et al. Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine. Scientific reports. 2016; 6:35455. Epub 2016/10/19. https://doi.org/10.1038/srep35455 PMID: 27752130; PubMed Central PMCID: PMCPmc5067576.
101. Volpe GE, Ward H, Mwamburi M, Dinh D, Bhalchandra S, Wanke C, et al. Associations of cocaine use and HIV infection with the intestinal microbiota, microbial translocation, and inflammation. Journal of studies on alcohol and drugs. 2014; 75(2):347–57. Epub 2014/03/22. PMID: 24650829; PubMed Central PMCID: PMCPmc3965688.
102. Dvorakova M, Jezova D, Blazicek P, Trebaticka J, Skodacek I, Suba J, et al. Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol). Nutritional neuroscience. 2007; 10(3–4):151–7. Epub 2007/11/21. https://doi.org/10.1080/09513590701565443 PMID: 18019397.
103. Verlaet AA, Ceulemans B, Verhelst H, Van West D, De Bruyne T, Pieters L, et al. Effect of Pycnogenol (R) on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial. Trials. 2017; 18(1):145. Epub 2017/03/30. https://doi.org/10.1186/s13063-017-1879-6 PMID: 28351412; PubMed Central PMCID: PMCPmc5370458.